Netherton Syndrome

🧠 Standard of Care & Symptoms

Netherton Syndrome is a severe, autosomal recessive congenital ichthyosis characterized by a classic clinical triad of skin scaling, hair defects, and immune system hypersensitivity.

• Presentation: The diagnostic triad.
  • Ichthyosis Linearis Circumflexa (ILC): Migratory, erythematous, circular plaques with a characteristic **double-edged scale** along the borders. This leads to chronic skin redness (erythroderma), severe itching, and peeling. Newborns often present as "collodion babies" or with generalized erythroderma, risking dehydration and hypernatremia.
  • Trichorrhexis Invaginata ("Bamboo Hair"): A pathognomonic hair shaft defect where the distal shaft invaginates (folds) into the proximal shaft, resembling bamboo joints. The hair is extremely short, sparse, and breaks easily. Eyebrows are also frequently affected.
  • Atopic Diathesis: Extremely high serum IgE levels, severe eczema-like skin flares, multiple food allergies, and Asthma.

🧬 Diagnostics & SPINK5 LEKTI Deficiency

Diagnosis requires high-magnification trichoscopy to identify hair shaft defects, skin biopsy, and genetic confirmation of SPINK5 alterations.

• Trichoscopy: Reveals node-like swellings (trichorrhexis invaginata) or golf-tee-shaped hairs.
• Skin Biopsy: Shows marked stratum corneum detachment (cleaving), psoriasis-like epidermal hyperplasia, and an absence of **LEKTI** protein staining on immunohistochemistry.
• Genetic Testing: Identification of biallelic pathogenic mutations in the **SPINK5** gene is confirmatory.

Pathophysiology & Kallikrein-Induced Desmosomal Cleavage

The skin peeling and inflammation in Netherton Syndrome are driven by uninhibited epidermal enzyme activity:

• SPINK5 and LEKTI: The **SPINK5** gene encodes **LEKTI** (lympho-epithelial Kazal-type-related inhibitor), a key serine protease inhibitor expressed in the outer layers of the epidermis (stratum granulosum).
• Uninhibited Serine Proteases: Without LEKTI, epidermal serine proteases—specifically **kallikrein-5 (KLK5)**, **kallikrein-7 (KLK7)**, and **kallikrein-14 (KLK14)**—become hyperactive.
• Desmosomal Shearing & Inflammation: These hyperactive kallikreins prematurely cleave desmosomal proteins, including **desmoglein 1** and **corneodesmosin**, which anchor skin cells together. This causes immediate detachment of the stratum corneum, complete skin barrier failure, and the release of pro-inflammatory cytokines (IL-33, TSLP) that drive the severe atopic allergies.

💊 Barrier Care, Retinoid Contraindications & Biologics

Management focuses on restoring skin barrier function, managing severe itch, and avoiding systemic toxicity from topical absorptions.

Strict Barrier Protection

• Avoid Exfoliants: Standard ichthyosis treatments (salicylic acid, alpha-hydroxy acids, high-dose urea) are strictly contraindicated due to the thin skin barrier, risking systemic absorption and chemical toxicity.
• Emollients: Daily, generous application of bland ointments (Petrolatum) to minimize water loss and protect from friction. Topical tacrolimus can be used but requires blood level monitoring due to increased absorption.

Targeted Biologic Therapies

• Dupilumab (anti-IL-4Rα): Monoclonal antibody that blocks IL-4 and IL-13 signaling. Although used off-label, Dupilumab has shown dramatic success in clinical reports, reducing pruritus, improving the skin barrier, and fading erythroderma in LEMS and ichthyosis cohorts.
• IVIG & Antibiotics: Regular intravenous immunoglobulin infusions and prompt topical/systemic antibiotics are required to manage recurrent skin infections (Staphylococcus aureus).

🔬 Active Clinical Trials

Clinical trials are currently evaluating selective kallikrein inhibitors, targeted monoclonal antibodies blocking the IL-36 and IL-17 axes, and gene replacement therapies designed to restore SPINK5 expression.

🗺️ Next Steps After Diagnosis

If you or a child have recently been diagnosed with Netherton Syndrome, coordinate these care pathways:

1. Examine Hair under Trichoscopy: Confirm the presence of "bamboo hair" (trichorrhexis invaginata) to support the diagnosis of Netherton syndrome.
2. Order genetic screening for SPINK5 mutations: Confirm the underlying genetic cause and assist in family counseling.
3. Stop all exfoliating skin acids: Ensure salicylic acid, glycolic acid, and high-strength urea are discontinued to prevent toxic absorption into the bloodstream.
4. Discuss Dupilumab therapy: Ask your dermatologist about starting Dupilumab off-label to help manage the severe redness and itching.

❓ Patient FAQ

Q: What is "bamboo hair" (trichorrhexis invaginata)?
A: Bamboo hair is a structural hair defect where the hair shaft is weak and folds in on itself. Specifically, the harder, outer tip of the hair shaft slides back into the softer, cup-like base of the shaft (like a nesting telescope or a bamboo joint). This makes the hair extremely brittle, dry, and prone to breaking off before it can grow long. It is a highly specific marker for Netherton syndrome.

Q: Why are standard peeling creams for dry skin dangerous for Netherton syndrome?
A: In most types of ichthyosis (dry, scaly skin), doctors prescribe exfoliating creams (containing salicylic acid or urea) to help peel off the thick scale. However, in Netherton syndrome, the skin is already extremely thin due to a lack of the LEKTI protein, which normally holds the skin layers together. Applying these peeling creams can cause the outer skin layer to peel off entirely, leaving raw, open skin. Furthermore, because the skin barrier is so compromised, these chemicals are rapidly absorbed into the bloodstream, which can lead to life-threatening toxicity.